Malignancy in ankylosing spondylitis: a cross-sectional analysis of a large population database

Abstract Background Increased cancer-risk has been reported with rheumatoid arthritis and systemic lupus erythematosus, but the risk is poorly studied in ankylosing spondylitis (AS). Conflicting data in AS have been reported in Asia and Europe, with lack of US population-based studies. Our objective...

Full description

Bibliographic Details
Published in:	BMC Rheumatology
Main Authors:	Mohamad Bittar, Sali Merjanah, Reem Alkilany, Marina Magrey
Format:	Article
Language:	English
Published:	BMC 2022-06-01
Subjects:	Ankylosing spondylitis Axial spondyloarthritis Malignancy Cancer Epidemiology
Online Access:	https://doi.org/10.1186/s41927-022-00275-x

Similar Items

CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2018-05-01)

Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01)

Advices for diagnostics of ankylosing spondylitis / axial spondyloarthritis: A review Part 2. Spinal column involvement
by: Nikolay V. Bunchuk, et al.
Published: (2024-05-01)

The incidence and prevalence of ankylosing spondylitis in Thailand using ministry of public health database
by: Ajanee Mahakkanukrauh, et al.
Published: (2024-07-01)

Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks
by: Helena Marzo-Ortega, et al.
Published: (2020-08-01)

Specific features of axial spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, in persons of different genders
by: A. P. Rebrov, et al.
Published: (2015-03-01)

COMPARATIVE EVALUATION OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
by: I. А. Cherentsova, et al.
Published: (2016-09-01)

Therapeutic Targets for Ankylosing Spondylitis – Recent Insights and Future Prospects
by: Perrotta FM, et al.
Published: (2022-04-01)

Anti-CD74 IGA antibodies, genetic polymorphisms and inflammatory activity in ankylosing spondylitis
by: V. I. Mazurov, et al.
Published: (2021-01-01)

Advices for diagnostics of ankylosing spondylitis/axial spondyloarthritis: A review
by: Nikolay V. Bunchuk, et al.
Published: (2023-11-01)

Remission in ankylosing spondylitis and axial spondyloarthritides: A modern understanding of the problem
by: I. Z. Gaydukova, et al.
Published: (2016-03-01)

IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?
by: Dominique Baeten, et al.
Published: (2021-02-01)

THE NEED AND POSSIBILITIES OF EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS: COMMENTARIES ON THE PAPER «EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS» (No. 4, 2013) AND DISCUSSION IN THE JOURNAL (No. 2, 2014)
by: Sh. F. Erdes
Published: (2014-09-01)

Features of ankylosing spondylitis at different stages in men and women
by: I. A. Cherentsova, et al.
Published: (2019-05-01)

Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis
by: Victoria Navarro-Compán, et al.
Published: (2023-02-01)

The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective study
by: Jie Chang, et al.
Published: (2024-01-01)

Probiotics in Ankylosing Spondylitis: A Possible Potency
by: Sumartini Dewi, et al.
Published: (2020-07-01)

Ankylosing spondylitis morbidity trends in Russia and Saturday spondyloarthritis schools
by: Shandor Fedorovich Erdes, et al.
Published: (2013-04-01)

Long-term efficacy and safety of netakimab in the treatment of ankylosing spondylitis: results of Phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA
by: V. I. Mazurov, et al.
Published: (2020-11-01)

Disease activity and functional outcomes in non-radiographic spondyloarthritis versus ankylosing spondylitis – preliminary results
by: Ana-Maria Doca, et al.
Published: (2022-09-01)

Clinical trial landscape for ankylosing spondylitis: Current insights and future innovations
by: Hui Li, et al.
Published: (2024-10-01)

Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity
by: Katarzyna Małgorzata Wiąk-Walerowicz, et al.
Published: (2024-03-01)

LABORATORY BIOMARKERS FOR ANKYLOSING SPONDYLITIS
by: E. N. Aleksandrova, et al.
Published: (2017-03-01)

Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway
by: Adam J. Berlinberg, et al.
Published: (2021-03-01)

A case of ankylosing spondylitis presenting with fever of unknown origin diagnosed as aortitis: A case report
by: Mahsa Mehdipour Dalivand, et al.
Published: (2023-11-01)

TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS
by: S. A. Lapshina, et al.
Published: (2016-09-01)

Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: Two-year results of the real word evidence LIBRA study
by: Sh. F. Erdes, et al.
Published: (2025-07-01)

USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS, MONITORING THEIR EFFICACY AND SAFETY (DRAFT GUIDELINES OF THE EXPERT SPONDYLOARTHRITIS DIAGNOSIS AND TREATMENT GROUP)
by: I. Z. Gaidukova, et al.
Published: (2016-09-01)

Spondyloarthritis in India
by: Anand N Malaviya
Published: (2020-01-01)

Pharmacoeconomic analysis of netakimab in the treatment of ankylosing spondylitis: perspective of Russian healthcare system
by: A. V. Rudakova, et al.
Published: (2025-02-01)

Spondyloarthritis associated with inflammatory myositis: An unusual case report
by: Pradip Kumar Prajapati
Published: (2019-01-01)

Korean treatment recommendations for patients with axial spondyloarthritis
by: Mi Ryoung Seo, et al.
Published: (2023-09-01)

Recent advances and prospects of axial spondyloarthritis / ankylosing spondylitis treatment
by: Sh. F. Erdes
Published: (2021-04-01)

Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials
by: Gerd R. Burmester, et al.
Published: (2024-04-01)

Disease activity and two-year sacroiliac joint changes according to instrumental study findings in a CoRSAr cohort of patients with early axial spondyloarthritis
by: Sh. Erdes, et al.
Published: (2019-05-01)

Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2016-09-01)

Physical function and sex differences in radiographic axial spondyloarthritis: a cross-sectional analysis on Bath Ankylosing Spondylitis Functional Index
by: Magnus Hallström, et al.
Published: (2023-09-01)

Internet-based nationwide evaluation of patient preferences for mobile health features in ankylosing spondylitis
by: Yiwen Wang, et al.
Published: (2023-05-01)

Efficacy and safety of a new original interleukin 17A inhibitor in the treatment of patients with active ankylosing spondylitis: results of a basic (BCD-085-3/AILAS) and extended (BCD-085-3ext/AILAS-II) phase II clinical trial
by: Sh. Erdes, et al.
Published: (2019-12-01)

OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01)